SCHEMBL19960129

SCHEMBL19960129

O=P(c1ccccc1)(c1ccccc1)c1cccc2c1nc1c3cc4ccccc4nc3c3ccccc3n21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP1 P11387 1/20 0.36
TOP2A P11388 2/20 0.34
NPC1 O15118 3/20 0.33
RAB9A P51151 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
KDM4E B2RXH2 8/20 0.33
MAPT P10636 7/20 0.33
ALDH1A1 P00352 6/20 0.33
KMT2A Q03164 5/20 0.33
HPGD P15428 5/20 0.33
LMNA P02545 3/20 0.33
POLB P06746 3/20 0.33
HSD17B10 Q99714 3/20 0.33
TP53 P04637 2/20 0.33
GLA P06280 1/20 0.33
GAA P10253 1/20 0.33
PTBP1 P26599 1/20 0.33
RCE1 Q9Y256 1/20 0.33
TSHR P16473 4/20 0.32
CASP1 P29466 4/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19965906 0.88 NPSR1 (0.36) TOP1TOP2ANPC1RAB9AL3MBTL1
SCHEMBL19960126 0.87 KDM4E (0.40) TOP1NPC1RAB9AL3MBTL1KDM4E
SCHEMBL19960118 0.86 TOP1 (0.39) TOP1KDM4EMAPTALDH1A1KMT2A
SCHEMBL19959768 0.84 TOP1 (0.40) TOP1KDM4EMAPTALDH1A1KMT2A
SCHEMBL19960120 0.84 KDM4E (0.40) TOP1NPC1RAB9AKDM4EMAPT
SCHEMBL19960127 0.84 KDM4E (0.42) NPC1RAB9AL3MBTL1KDM4EMAPT
SCHEMBL19959862 0.84 TOP1 (0.35) TOP1TOP2ANPC1RAB9AKDM4E
SCHEMBL19960135 0.83 MAPT (0.39) TOP2ANPC1RAB9AL3MBTL1KDM4E
SCHEMBL19960124 0.82 KDM4E (0.38) TOP1NPC1RAB9AKDM4EMAPT
SCHEMBL19960136 0.82 MAPT (0.38) TOP2ANPC1RAB9AL3MBTL1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10700289-B2 Heterocyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2020-06-30 US disclosed
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-03-15 US disclosed
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, PER2 TOP1 2543/4885TOP2A 2699/4885NPC1 3974/4885
US-10700289-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, PER2 TOP1 2543/4885TOP2A 2699/4885NPC1 3974/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.